NasdaqGS:MRNABiotechs
Moderna (MRNA) Valuation Check After Sharp Multi‑Month Share Price Rebound
Moderna (MRNA) has been back on many investors’ screens after a sharp move in recent months, with the stock up about 30% over the past month and roughly 78% in the past 3 months.
See our latest analysis for Moderna.
While the share price has eased slightly over the last day, Moderna’s recent 30-day share price return of about 30% and year to date gain of roughly 70% point to building momentum, even as the 3 and 5 year total shareholder returns remain deeply negative.
If Moderna’s recent...